Overview
Keliang Li practices practicing medicine in Zhengzhou, China.
Their clinical expertise encompasses Cavernous Lymphangioma, Pancreatic Ductal Adenocarcinoma, Hereditary Pancreatitis, and Pancreatic Cancer.
They are actively involved in clinical research, co-authoring 13 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Keliang Li
Is Keliang Li a top-rated expert for Cavernous Lymphangioma?
MediFind is an objective health platform that identifies experts based on real-world data. Keliang Li is classified as an Experienced expert for Cavernous Lymphangioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Keliang Li participate in research or clinical trials?
Yes. Keliang Li has published 13 articles and abstracts on conditions like Cavernous Lymphangioma. You can view a list of Keliang Li's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cavernous LymphangiomaLi isExperienced. Learn about Cavernous Lymphangioma.
- Hereditary PancreatitisLi isExperienced. Learn about Hereditary Pancreatitis.
- Pancreatic CancerLi isExperienced. Learn about Pancreatic Cancer.
- Pancreatic Ductal Adenocarcinoma